Phase
Condition
Hemangioma
Treatment
N/AClinical Study ID
Ages 20-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age between 20-70 years old;
Hepatic hemangioma patients who will undergo laparotomy surgery: diameter of hepatichemangioma between 5-15cm, located in the right liver;
Child score 5-6;
BMI: 19-25;
ASA: Ⅰ ~ Ⅱ grade;
No comorbidities such as diabetes, hypertension, cardio renal or respiratorydysfunction, mental illness;
No known allergies;
No participation in other clinical trials within 2 months;
Have been informed consent.
Surgery-related: right subcostal incision, surgical time< 4 hours, hepatic pedicleocclusion time< 20 minutes, bleeding< 1000ml, no blood transfusions.
Exclusion
Exclusion Criteria:
History of chronic pain,long-term use of analgesic drugs or alcohol abuse;
Allergic to NSAIDs, opioids or sulfa drugs;
Coagulopathy or other hematological disorder;
Active peptic ulcer, gastrointestinal bleeding, inflammatory bowel disease;
Pregnant or lactating;
Mentally unstable to use PCA;
Preoperative pain caused by other disease;
Analgesic drugs or NSAIDs intake one week before surgery;
Preoperative systemic inflammatory response syndrome;
Preoperative chemotherapy or radiotherapy;
Preoperative or postoperative use of steroids;
Operative time> 4 hours, hepatic pedicle occlusion time> 20 minutes, blood loss> 1000ml, or intraoperative blood transfusion;
TBil> 34 umol/L、PT prolongation> 3S、ALB< 30 g/L、or Child score> 7 within 42 hoursafter surgery;
Bleeding、biliary fistula, intra-abdominal infections or other postoperativecomplications.
Study Design
Connect with a study center
Peking union medical college hospital
Beijing, Beijing 100032
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.